<SEC-DOCUMENT>0001493152-25-020653.txt : 20251104
<SEC-HEADER>0001493152-25-020653.hdr.sgml : 20251104
<ACCEPTANCE-DATETIME>20251103182412
ACCESSION NUMBER:		0001493152-25-020653
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20251031
FILED AS OF DATE:		20251104
DATE AS OF CHANGE:		20251103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Genenta Science S.p.A.
		CENTRAL INDEX KEY:			0001838716
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L6

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41115
		FILM NUMBER:		251445684

	BUSINESS ADDRESS:	
		STREET 1:		OLGETTINA, NO. 58
		CITY:			MILAN
		STATE:			L6
		ZIP:			20132
		BUSINESS PHONE:		39-02-2643-6639

	MAIL ADDRESS:	
		STREET 1:		OLGETTINA, NO. 58
		CITY:			MILAN
		STATE:			L6
		ZIP:			20132

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Genenta Science S.r.l.
		DATE OF NAME CHANGE:	20210104
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
6-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF FOREIGN PRIVATE ISSUER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the month of October 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commission
File Number: 001-41115</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>GENENTA
SCIENCE S.P.A.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Translation
of registrant&rsquo;s name into English)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Via
Olgettina No. 58</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20132
Milan, Italy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of Principal Executive Offices)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 49%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form 20-F
&#9746;</FONT></TD><TD STYLE="width: 2%"></TD><TD STYLE="text-align: justify; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Form
40-F &#9744;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report on Form 6-K is incorporated by reference into the registrant&rsquo;s registration statement on Form F-3 (File No. 333-271901).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 29, 2025, Genenta Science S.p.A. (the &ldquo;Company&rdquo;) held its Ordinary and Extraordinary Shareholders&rsquo; Meeting
in virtual meeting format. At the Ordinary and Extraordinary Shareholders&rsquo; Meeting, the Company&rsquo;s shareholders approved the
following resolutions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amendment to Article 4 of the Company&rsquo;s by-laws to extend the Company&rsquo;s corporate
                                            purpose to include all sectors covered by the Italian Law Decree 21/2012 (i.e. <I>Golden
                                            Power legislation</I>);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            increase in the number of members of the Board of Directors from three (3) to five (5) members;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            appointment of two new directors to the Company&rsquo;s Board of Directors, Miguel Maria
                                            Mutti and Giacomoantonio Paracchi, effective as of October 29, 2025, to serve until the Company&rsquo;s
                                            Shareholders&rsquo; Meeting approving the financial statements as of December 31, 2025. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49.65pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Armon
R. Sharei, Ph.D., Francesco Galimi, M.D., Ph.D., and Pierluigi Paracchi, Chief Executive Officer, will continue to serve on the Board
of Directors; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49.65pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            grant the newly appointed directors an aggregate annual gross compensation of &euro;60,000
                                            per year, to be distributed among them by the Board of Directors. Therefore, the overall
                                            remuneration of the entire Board is to be considered redetermined in the amount of &euro;165,000.
                                            </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new director, Miguel Maria Mutti, is a senior executive with over 25 years of international experience in the pharmaceutical and investment
banking sectors. He has a proven track record in corporate and business development, M&amp;A, licensing, and general management, having
led major growth, restructuring, and integration projects across Europe, Latin America, and Asia. Currently, he serves as Managing Partner
at Sinergetica Healthcare, a strategic consulting and investment firm focused on pharma, biotech, and medtech. Before that, he held senior
leadership roles at Lupin Limited, Gr&uuml;nenthal GmbH, Chemo Group, and Citigroup. Mr. Mutti combines strategic vision, financial expertise,
and hands-on operational leadership, supported by an MBA from ISTUD and executive training at INSEAD. He is fluent in Italian, Spanish,
and English.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new director, Giacomoantonio Paracchi, is a business lawyer with extensive experience as General Counsel and Head of Legal &amp; Corporate
Affairs within structured multinational groups. Since September 2023, he has been serving as General Counsel of the Geodis Group, and
since May 2025, he has also joined LEXIA as a Partner in the Corporate / M&amp;A / Capital Markets Department. Previously, he held senior
legal and corporate positions at Comifar Group, Valtellina Group, and Techint Group, overseeing legal, corporate affairs, and compliance
functions. His professional background is complemented by an excellent command of the English language and a strong focus on business-oriented
legal strategy. Mr. Paracchi is the brother of Pierluigi Paracchi, the Company&rsquo;s Chief Executive Officer, Chairman and co-founder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effectiveness of the by-laws amendment to Article 4, extending the Company&rsquo;s corporate purpose to include all sectors covered by
the Italian Golden Power legislation, is expressly conditioned upon the non-exercise of the withdrawal right (<I>diritto di recesso</I>)
granted to shareholders who did not vote in favor of the resolution (as absent, abstained, or voted against).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
even a single withdrawal be validly exercised, the above by-laws amendment will not take effect; therefore, in this case, the exercise
of the right of withdrawal will not entitle the withdrawing shareholder to the liquidation of the relevant shares, and will only determine
the ineffectiveness of the resolution of the Shareholders&rsquo; Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right of withdrawal must be exercised pursuant to Article 2347-<I>bis</I> of the Italian Civil Code, by sending a registered letter to
the Company within fifteen days from the registration of the shareholders&rsquo; resolution in the Companies&rsquo; Register, <I>i.e.</I>
by about November 15, 2025. The letter must include the shareholder&rsquo;s personal details, the address for communications related
to the procedure, and the number of shares for which the right of withdrawal is exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
any further information, shareholders who intend to exercise the right of withdrawal are kindly invited to contact the Company at the
certified e-mail address amministrazione@genenta.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above description of the by-laws amendment is qualified in its entirety by reference to the by-laws, a copy of which is filed as Exhibit
3.1 hereto and is incorporated herein by reference (please note that such copy of the by-laws do not provide yet the current amount of
the Company&rsquo;s share capital following the issuance of n. 4,285,715 new shares in the context of the capital increase and the related
offering pursuant to the prospectus supplement filed on October 28, 2025; such updated by-laws will be filed with the Companies&rsquo;
Register, in accordance with Article 2444 of the Italian Civil Code, within 30 days from the execution of the capital increase).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibits</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex3-1.htm">Amended By-laws of Genenta Science S.p.A.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENENTA
    SCIENCE S.P.A.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    November 3, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Richard B. Slansky</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    B. Slansky</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><B><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>BY-LAWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>TITLE I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>CORPORATE NAME &ndash; CORPORATE PURPOSE
&ndash; REGISTERED OFFICE &ndash; SHAREHOLDERS&rsquo; DOMICILE &ndash; TERM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 1 &ndash; Corporate name</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A joint stock company has been incorporated under
the name: &ldquo;<B>Genenta Science S.p.A.</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 2 &ndash; Registered office</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">2.1 The Company has its registered
office in the Municipality of Milan, at the address resulting from the registration with the Register of Enterprises of Milan, pursuant
to section 111-ter of the preliminary dispositions prefacing the Italian Civil Code and transitory provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">2.2 The Board of Directors is
entitled to establish or close down, both in Italy and abroad, local units (such as, for instance, branch offices, subsidiaries, administrative
offices, representative offices, warehouses and stores), or to resolve upon the establishment of secondary offices or upon the transfer
of the registered office to a Municipality other than the one above indicated, provided that it is within the national territory of Italy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 3 &ndash; Shareholders&rsquo; domicile</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">A shareholder&rsquo;s address
for all relationships with the Company is deemed to be the address resulting from the Shareholders&rsquo; ledger. Each Shareholder must
communicate any change in address to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 4 &ndash; Corporate purpose</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company achieves the following purpose:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">research, development, production, mass production and sale of new therapeutic compounds of bio-technological, biologic and chemical origin relating to the pharmaceutical, biotechnological, molecular and cellular medicine, genetic and diagnostic segments of industry (hereinafter also the &ldquo;<B>Business</B>&rdquo;);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">production, processing of materials and provision of services in relation to the Business;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">development and improvement of new technologies and procedures in relation to the Business;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mass production, production and distribution on own behalf and on behalf of third parties of pharmaceutical and para-pharmaceutical products, bio-technological, biologic and chemical products and their derivatives;</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">promotion and organization or updates to its offering of scientific courses.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">The Company also has as its purpose
the research, development, production and commercialization, both in Italy and abroad, of products, services, technologies and applications
in all sectors contemplated by the Italian legislation on the exercise of special powers (so-called &ldquo;Golden Power&rdquo;) in force
from time to time, as well as any related, instrumental and complementary activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">In order to achieve the Company
purpose, the Company may execute any transaction it considers necessary or useful, albeit only secondarily and only as a means to achieving
its stated purpose, which may involve transactions in securities, real property, commercial, industrial or financial in nature, including
taking on mortgages and unsecured debt, in any form, with private individuals, companies, and banks, and issue collateral and other guarantees,
including personal guarantees, letters of indemnity and guarantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">The Company may also take on
and sell, directly or indirectly, interests in or investments in other companies or enterprise whether established or in the process of
establishment, whose purpose is similar, related or in any way connected to its own. Expressly excluded from the company purpose is any
activity vis-&agrave;-vis the public that the law defines as &ldquo;financial activity&rdquo; and, except in certain cases and the full
compliance with the related provisions set forth by law, any reserved professional activities and activities allowed by law only to certain
individuals and legal entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 5 &ndash; Duration</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The term of the Company is scheduled to expire on
31 December 2050.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TITLE II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CAPITAL AND SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 6 &ndash; Capital and shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">6.1 The corporate capital of
the Company is equal to Euro 464,646.80 and is divided into number 19,146,468 shares without an expressed nominal value. Pursuant to section
2441 of the Italian Civil Code, the corporate capital may be increased and subscribed proportionately by the shareholders, all at once
or at different times, through contributions in kind and/or contributions of receivables and/or capitalization of available reserves,
by means of resolutions of the Shareholders&rsquo; meeting and in compliance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">6.2 The corporate capital may also be increased by
issuing shares entailing rights other than those granted by the previous shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">6.3 The capital increase may
take place through contribution in cash or in kind or of receivables, whether proportional or not, in compliance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">6.4 The shareholders may also
grant the Company loans, which shall be governed by the laws and regulations then in effect. Shareholder loans calling for repayment of
principal need not be made in proportion to shares held in the Company&rsquo;s corporate capital, in compliance with procedures and restrictions
set out in applicable laws and regulations in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">6.5 Pursuant to section 2346,
par. 1, of the Italian Civil Code, unless otherwise provided by applicable law, evidencing shares representing the Company&rsquo;s capital
shall not be represented by share certificates. The shares shall be uncertificated (<I>dematerializzate</I>) pursuant to section 83-bis
<I>et seq</I>. of Legislative Decree no. 58 of 24 February 1998.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">6.6 Pursuant to section 2443
of the Italian Civil Code, Shareholders acting at a properly convened Shareholders&rsquo; meeting may delegate to the Board of Directors
the power to increase the corporate capital, on one or more occasions, up to a specified amount for a period not to exceed the maximum
term of five years from the date of the relevant resolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>The shareholders&rsquo; meeting dated 20 May 2021
resolved to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>to increase the share capital against payment, in one or more instalments on a divisible basis, excluding the preemption right under Article 2441 paragraph 5, Italian Civil Code up to a maximum sum of Euro 115,000,000 (including share premium), with a contribution to the share capital of Euro 0.10 per share, by issuing a maximum of 11,500,000 new ordinary shares with no indication of their nominal value and with regular dividend entitlement, in order to service the admission of the Company&rsquo;s ADSs to listing on the Nasdaq Capital Market, granting a mandate to the Board of Directors to execute, even in several tranches, the proposed capital increase, in the amounts indicated above, by 31 December 2021, of which a maximum of 10,000.000 ordinary shares, for a countervalue of Euro 100,000,000 (including share premium), to service the IPO (i.e. the ADS Placing and the Reserved Shareholders&rsquo; Placing); a maximum of 1,500.000 ordinary shares (and in any case up to a maximum limit of 15% of the number of shares that will be issued servicing the IPO and the admission of the Company to listing on the Nasdaq Capital Market), for a countervalue of Euro 15,000,000 (including the share premium), servicing the possible exercise of the Greenshoe Option;</I></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>to grant the Board of Directors, in accordance with the Article 2443 of the Italian Civil Code, the power to approve the issuance of up to a maximum of 500,000 warrants to be assigned to the Underwriters, approving the related regulations, and therefore the power to further increase the share capital in one or more tranches to service the exercise of the warrants by a further maximum nominal amount of Euro 5,000,000 (including share premium), with a contribution to the share capital of Euro 0.10 per share, through the issuance of up to a further maximum of 500,000 ordinary shares (and therefore the power to increase the share capital in one or more tranches) by Euro 0.10 per share, to service the exercise of the Greenshoe Option; and 500,000 ordinary shares (and in any case within the maximum limit of 4% of the ADSs servicing the IPO and the criteria set forth in the agreements entered into by the Company in connection with the IPO), represented by ADSs, faculty to be exercised no later than 31 December 2021 (it being understood that the Board of Directors may, when exercising its delegated powers, set the terms and conditions of the issue) with the express waiver by the shareholders of any further terms and conditions when exercising the proxy;</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>to increase the share capital against payment, in one or more instalments on a divisible basis, excluding pre-emption right under Article 2441, paragraph 5 of the Italian Civil Code, up to a maximum amount of Euro 1,000,000 (one hundred and twenty-five per cent), up to a maximum amount of Euro 27,000,000 (including share premium) with a contribution to the share capital of Euro 0.10 per share, through the issue of up to 2,700,000 new ordinary shares with no indication of their express par value and regular dividend rights (and in any case within the maximum limit of 10% of the number of shares outstanding at the time of issue in addition to those that may be issued based on the existing Warrants), to service the stock option plan called &ldquo;2021 &ndash; 2025 Stock Option Plan&rdquo;, authorizing the Board of Directors to execute the proposed capital increase, even in several tranches, by the deadline of 31 December 2035, as well as to define the issue price and the amount to be allocated to share capital and the amount to be allocated to share premium;</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>to grant the Board of Directors a proxy, pursuant to Article 2443 of the Italian Civil Code, to increase the share capital against payment, in accordance with the provisions of Article 2443 of the Italian Civil Code, to increase the share capital for cash, on one or more occasions and in separate issues, up to a maximum amount of Euro 300,000,000 (including share premium), by issuing up to 30,000,000 new ordinary shares with no indication of their express par value and regular dividend rights, also excluding pre-emption rights or on a free basis, also pursuant to Article 2441, paragraphs 4, 5 and 8 of the Italian Civil Code, for a period of 5 years, in accordance with Article 2441, paragraph 2 of the Italian Civil Code. The Board of Directors may also grant a proxy pursuant to Article 2420-ter of the Italian Civil Code, for a period of 5 years, for the contribution by third parties of equity investments and/or industrial and intellectual property rights and similar intangible assets (such as patents, trademarks, know-how) that can be conferred and are deemed by the Board of Directors to be instrumental to the achievement of the corporate purpose, to issue, in one or more instalments, bonds convertible into ordinary shares, up to the same maximum total amount of Euro 300,000,000 (including share premium), with a consequent increase in share capital to service the conversion, also excluding pre-emption right, also pursuant to Article 2441, paragraphs 4, 5 and 8 of the Italian Civil Code for a period of 5 years.</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>The Board of Directors, by resolution dated November
8, 2021, in execution of the authority granted by the shareholders&rsquo; meeting dated May 20, 2021, resolved to increase the share capital
of a maximum amount of Euro 5,000,000 (including share premium), with a contribution to the share capital of Euro 0.10 per share, to be
executed, in one or more instalments, by issuing a maximum of no. 500,000 ordinary shares with a nominal value of EUR 0.10 each (and in
any case within the maximum limit of 4% of the ADSs to the service of the IPO and according to the criteria set out in the agreements
entered into by the Company in relation to the IPO) within the final term of December 31, 2026.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>The Board of Directors, by a resolution dated May
10, 2023, in execution of the authority granted by the extraordinary Shareholders&rsquo; Meeting on May 20, 2021, resolved to increase
the share capital to the service of the ATM Offering contemplated by the ATM Prospectus and the Sales Agreement up to an amount equal
to the equivalent in euros of USD 30,000. 000, (including share premium), to be determined in accordance with the exchange ratio existing
at the date of each transaction carried out pursuant to the ATM Prospectus, charging to capital EUR 0.10 per share, to be carried out
also in several tranches, with the exclusion of pre-emptive rights and within the final deadline of May 31, 2026, providing that the maximum
number of shares to be issued under the Offering Increase will be determined within the limits of the maximum number of shares provided
for under the above mentioned authorization and the implicit par value of the newly issued shares, according to the ratio between the
maximum countervalue of this capital increase and the price at which the shares will be, from time to time, issued, the latter determined
according to methodologies customary for this type of transaction and, in any event, not less than the minimum bid price recorded on Nasdaq
by the ADSs on the day of execution of each offering.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>The Board of Directors, by resolution dated February
26, 2025, in execution of the delegation granted by the extraordinary shareholders&rsquo; meeting on May 20, 2021, has resolved to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>1.</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Approve the issuance, by June 30, 2025, of mandatory convertible bonds into newly issued ordinary shares of the Company pursuant to Article 2420-bis of the Italian Civil Code for a total amount of EUR 20,000,000.00. The bonds will have the characteristics set forth in the regulations of the loan &ldquo;MANDATORY CONVERTIBLE LOAN GENENTA 2025-2028&rdquo; and will be offered for subscription to the Enea Foundation.</I></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>2.</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Approve the Regulations, expressly mandating the Chairman of the Board of Directors, with the power to sub-delegate, within the limits and under the conditions set forth in the adopted resolutions, to make any updates and amendments deemed necessary and/or appropriate.</I></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>3.</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Increase the share capital, in a divisible manner, by a maximum amount of EUR 20,000,000.00, to be executed within a maximum period of three years from the issuance of the mandatory convertible bonds, exclusively to serve the conversion of the mandatory convertible bonds (as per point 1 above), through the issuance of a maximum number of ordinary shares resulting from the application of the conversion ratio specified in the Regulations, with the Board of Directors being authorized to determine the portion of the increase to be allocated to share capital and the portion to be allocated to share premium.</I></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>The Board of Directors, by resolution dated October
26, 2025, in execution of the delegation granted by the Extraordinary Shareholders&rsquo; Meeting held on May 20, 2021, resolved to increase
the share capital to service one or more Shelf Offerings contemplated by the Base Prospectus, which shall in any case be considered additional
to those resolved upon by the previous 2023 resolution serving the overall transaction in which such issuance is included, for an amount
equal to the euro equivalent of USD 100,000,000 (including share premium), to be determined based on the exchange rate in effect at the
date of each transaction carried out pursuant to the relevant supplement to the Base Prospectus. An amount of Euro 0.10 per share shall
be allocated to share capital. The capital increase may be carried out in one or more tranches, with exclusion of the pre-emptive right,
and within the final deadline of May 31, 2026. The maximum number of Shares to be issued under the Delegated Capital Increase shall be
determined, within the limits of the maximum number of Shares authorized under the Delegation and the implicit accounting par value of
the newly issued Shares, based on the ratio between the maximum amount of the Delegated Capital Increase and the price at which the Shares
will, from time to time, be issued, such price to be determined using customary methodologies for this type of transaction and in accordance
with the relevant supplement to the Base Prospectus.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 7 &ndash; Transfer of Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The shares may be freely transferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TITLE III</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DEBT SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 8 &ndash; Issuance of Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">The Board of Directors may approve
the issuance of debt securities (<I>obbligazioni</I>) in registered or bearer form, with the terms and conditions thereof to be set forth
in the applicable resolutions of the Board of Directors, subject to compliance with section 2412 of the Italian Civil Code. Shareholders
acting at a properly convened Shareholders&rsquo; meeting may resolve to issue convertible debt securities, with the conversion rate and
other terms and conditions, including conversion procedures being set forth in the applicable resolutions, as well as to issue participating
securities, with the terms and conditions thereof being set forth in the applicable resolutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TITLE IV</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 9 &ndash; Shareholders&rsquo; meetings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">9.1 Shareholders&rsquo; meetings
shall be held at the registered office of the Company or elsewhere, provided that the location is in Italy or in another country within
the European Union or in the United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Shareholders&rsquo; meetings
can be called at any time as the Board of Directors deems it necessary or upon request by Shareholders representing at least 10% of the
share capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Ordinary Shareholders&rsquo;
meetings shall be held at least once a year, within 120 days following the end of the financial year or, if special circumstances so warrant
or the Company is required to prepare consolidated financial statements, within 180 days following the end of the financial year. In such
cases the Board of Directors shall specify the reasons for such extension in its report to Shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">9.2 Shareholders with voting
rights are entitled to attend Shareholders&rsquo; meetings. The right to attend the meeting and exercise voting rights shall be attested
by a a report of eligible Shareholders delivered to the Company by the transfer agent based on its books and records as of the close of
business on the seventh business day prior to the date established for the Shareholders&rsquo; meeting (assuming that the meeting is convened
on the earliest date noticed to Shareholders).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Subject to applicable law, Shareholders
entitled to vote at a Shareholders&rsquo; Meeting may vote in advance of the Shareholders&rsquo; Meeting by mail or, if specified in the
notice of the meeting, electronically in such manner as specified therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">9.3 Shareholders&rsquo; meetings,
both ordinary and special, shall be called by notice published in the Italian daily newspaper &ldquo;Il Sole 24 Ore&rdquo; at least fifteen
days prior to the date of the meeting or otherwise given by the Company, provided that so long as the Company is allowed by applicable
Italian law, by sending, either in the alternative to or in addition to the foregoing published notice, a notice to the Shareholders,
to the members of the Board of Directors and to the members of the Board of Auditors, by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">registered mail with return receipt requested;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e-mail with electronic acknowledgment of receipt;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">as long as the notice is received by the addressee
at least 8 calendar days before the date set for the meeting with evidence thereof as provided above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The notice shall also be posted on the Company&rsquo;s
web site.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">The notice shall set forth the
agenda for the meeting as well as the date and place where the meeting is to be held and the date for an adjourned meeting in the event
a quorum is missing on the original date set for the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9.4 The Shareholders&rsquo; meeting shall be chaired
by a person selected by those in attendance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9.5 Both ordinary and special Shareholders&rsquo;
meetings may also be held via teleconference or videoconference, provided that all participants can be identified, that they can follow
the discussion and that they can hear and be heard live with respect to the matters on the agenda and are able to express their vote simultaneously
on such items.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">The meeting notice may specify
alternative locations, whether in the registered office or elsewhere, where Shareholders may convene to participate via teleconference
or videoconference connection.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Should these conditions be met,
it is not necessary for the person chairing the meeting and the person acting as secretary for the meeting to be present at the same location.
The meeting shall be deemed to be held at the location where the person acting as secretary to record the minutes of the meeting is present.
In the event that the above conditions are not met, the meeting shall be deemed to have been validly convened and held so long as the
entire share capital is present or duly represented and a majority of the members of the Board of Directors and the Board of Auditors
are in attendance; provided that in such event, any Shareholder or other participant present may object to the discussion of items with
respect to which he/she does not deem to have been adequately informed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9.6 A Shareholders&rsquo; meeting shall be deemed
to have been validly called and convened and can duly act according to such majorities as provided by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9.7 At an ordinary Shareholders&rsquo; meeting Shareholders
may adopt resolutions with respect to any and all matters as to which Shareholders have the power to vote pursuant to applicable law or
this corporate charter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9.8 At a special Shareholders&rsquo; meeting Shareholders
may adopt resolutions with respect to any amendments to this corporate charter, the issuance of debt securities convertible into shares,
any issuance of additional shares (<I>aumento di capitale</I>), the appointment, replacement and powers of receivers and liquidators,
and any and all other matters as to which Shareholders have the power to vote pursuant to applicable law or this corporate charter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9.9 Each share entitles the holder to one vote, subject
to the provisions of this Bylaws with respect to particular classes of shares and subject to Article 9.11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9.10 Any shareholder may name a proxy to represent
such Shareholder at the Shareholders&rsquo; meeting subject to section 2372 of the Italian Civil Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9.11 Each share shall entitle the shareholder to a
double vote (i.e. two votes for each share) if the share has been held by the same entity for a continuous period of not less than twenty-four
months from the date of its registration in the register of shareholders as set out below. An additional vote shall also be granted upon
the expiration of each twelve-month period, following the expiration of the period referred to above, in which the share has been held
by the same entity, up to a total maximum of ten votes per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For this purpose, a special list, governed by this
Article (the &ldquo;Special List&rdquo;), is included in the shareholders&rsquo; register. In order to obtain the increase, the shareholder
must submit a specific application, enclosing a communication certifying the share ownership &ndash; which may also concern only part
of the shares held by the shareholder &ndash; issued by the intermediary with whom the shares are deposited pursuant to the laws in force.
In the case of entities other than individuals, the application must specify whether the entity is subject to direct or indirect control
by third parties and the identification data of the controlling entity, if any. The Special List is updated by the Company. The Company
proceeds to the cancellation from the Special List in the following cases: renunciation of the interested party; communication of the
interested party or of the intermediary proving the loss of the prerequisites for the increase of the voting right or the loss of the
ownership of the right; ex officio, when the Company is informed of the occurrence of facts that entail the loss of the prerequisites
for the increase of the voting right or the loss of the ownership of the right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The increased voting right shall cease to exist: in
the event of a transfer for consideration or free of charge of the share, it being understood that &ldquo;transfer&rdquo; also means the
establishment of a pledge, usufruct or other encumbrance on the share when this entails the loss of voting rights by the shareholder;
in the event of direct or indirect transfer of controlling shareholdings in companies or entities that hold shares with increased voting
rights. The increased voting rights: are preserved in the event of succession due to death in favour of the heir and/or legatee; are preserved
in the event of a merger or demerger of the holder of the shares in favour of the company resulting from the merger or beneficiary of
the demerger; are proportionally extended to newly issued shares in the event of a capital increase pursuant to Art. 2442 of the Italian
Civil Code and an increase in capital through new contributions made in the exercise of option rights; it may also apply to shares assigned
in exchange for shares to which the increased voting right is attributed, in the event of a merger or demerger if so provided by the relevant
project. The right of the person to whom the increased voting right is assigned to irrevocably renounce (in whole or in part) the increased
voting right at any time, by means of a written notice to be sent to the Company, it being understood that the increased voting right
may be reacquired with respect to the shares for which it was renounced with a new entry in the Special List and the full expiry of the
period of continuous membership of not less than 24 months. The increased voting right is also counted for the purposes of determining
constitutive and deliberative quorums which refer to share capital ratios, but has no effect on the rights, other than voting rights,
accruing by virtue of holding certain share capital ratios. For the purposes of the continuous ownership provided for in this paragraph,
ownership prior to the date of registration in the Special List is also taken into account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TITLE V</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 10 &ndash; Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.1 The Company shall be managed
by a Board of Directors composed of a minimum of three directors and a maximum of seven directors, as determined by the resolution of
the shareholders at the time of the election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The non-compete obligation upon directors, pursuant
to Article 2390 of the Italian Civil Code, does not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Candidates for election to the
Board of Directors shall be elected on the basis of slates submitted by shareholders, on which candidates must be listed in the order
in which they will be elected on the basis of the requisite vote. Slates shall be deposited at the Company&rsquo;s registered office no
later than twentyfive calendar days prior to the date set for the Shareholders&rsquo; Meeting for which the election of directors is on
the agenda. Any Shareholder, acting individually or through a nominee, may submit or join in the submission of a single slate and may
cast its vote for a single slate. Each candidate for election to the Board of Directors may be listed on a single slate, and shall automatically
be ineligible for election if named on multiple slates. Only Shareholders who, alone or together with other Shareholders joining in the
submission of the slate, represent at least 6% of the voting rights at the Shareholders&rsquo; meeting at which directors are to be elected,
are eligible to submit the slates, such eligibility to be established by filing an appropriate certification to that effect. Certification
of the ownership of the number of shares necessary for submission of a slate must be produced at the time of deposit of the slate or at
a later date, provided that such certification is provided by the deadline for the deposit of a slate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Together with and at the same
time as the deposit of a slate, the following shall be filed, with failure to comply with such filing requirements leading to the candidates
named on the slate being automatically ineligible for election: (i) biographical information for each candidate; (ii) information on the
identity of the Shareholders who have submitted the slate, with an indication of the total percentage of the Company&rsquo;s share capital
held: (iii) consent by each candidate to be named in the slate and certification, under his/her own responsibility, that no grounds for
ineligibility or incompatibility to serve as a member of the Board of Directors, as well as the satisfaction of the requirements prescribed
by applicable law to be a director of the Company, including, where applicable, whether the candidate would be an independent director,
if elected, and (iv) such other statements or information as required by law or applicable securities exchange rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt"><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Any slates submitted without compliance with the above
requirements shall be deemed not to have been submitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Directors shall be elected as
follows: a) candidates for election as directors equal to the number of seats on the Board of Directors minus 1 shall be selected from
the slate that receives the greatest number of votes cast (the &ldquo;Majority Slate&rdquo;) shall be elected in the order in which they
are listed on the slate; b) the first candidate listed on the slate that receives the second greatest number of votes cast (the &ldquo;Minority
Slate&rdquo;) shall be elected as director so long as the Minority Slate is not connected in any way, directly or indirectly, with the
Shareholders who submitted or voted for the Majority Slate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">In the event that the Majority
Slate does not contain a sufficient number of candidates to fill the number of vacancies on the Board of Directors to be filled as provided
in clause a) above, all candidates listed in the Majority Slate shall be elected directors and the remaining directors shall be elected
from the Minority Slate according to the order in which they are listed in such slate. The voting procedure according to slates provided
above shall be applicable only in case of election of the entire Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">In the event of a tie between
slates, a new vote shall be taken and the candidates obtaining the largest number of votes shall be elected without regard to the slate
on which they are listed or application of the slate voting mechanism.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Should a single slate be submitted,
the Shareholders eligible to vote at the meeting shall cast their vote on such slate and, so long as more votes are cast for such slate
than votes cast against such slate, all the members of the Board of Directors shall be elected from that slate in accordance with applicable
law at the time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">If no slates are submitted, or
a single slate is submitted and such slate does not obtain the requisite number of votes, or the number of directors to be elected on
the basis of the slates submitted is less than the full number of directors to be elected, or the entire Board of Directors is not to
be entirely elected, or it is otherwise not possible for any reason to elect the Board of Directors in accordance with the provisions
of this title, the members of the Board of Directors shall be elected at the Shareholders&rsquo; meeting in accordance with generally
applicable procedures and required majorities under applicable law, without application of the slate voting mechanism.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">10.2 Directors shall be elected for a three-year term
and may be re-elected, except as otherwise resolved by Shareholders at the time of their election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.3 The Board of Directors shall
appoint a Chairman among its members, unless the Chairman is not appointed by a vote of Shareholders&rsquo;, as well as a Deputy Chairman.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.4 Meetings of the Board of
Directors may be called by the Chairman or the Deputy Chairman and shall be called upon request by at least one director or by the Board
of Auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">10.5 Resolutions of the Board of Directors&rsquo;
shall be deemed validly adopted if a majority of directors in office are present at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">10.6 Resolutions of the Board of Directors shall be
deemed approved with the favourable vote of a majority of the directors present at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.7 The Board of Directors may
act with respect to any and all matters related to the ordinary and extraordinary affairs of the Company as necessary and/or appropriate
for the conduct of the Company&rsquo;s business in accordance with its purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="ex3-1_001.jpg" ALT="" STYLE="width: 200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board of Directors shall also have authority with
respect to the following matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">resolutions concerning mergers in the cases referred to in Articles 2505, 2505-bis and 2506-ter of the Italian Civil Code;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduction of the share capital in case of withdrawal of a shareholder;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">amendments to the Articles of Association to comply with applicable law provisions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.8 The Board of Directors may
establish one or more committees with advisory, deliberative or oversight functions in accordance with applicable laws and regulations
in whatsoever applicable jurisdiction, as well as with codes of conduct and corporate governance best practices. If one or more committees
are established, their composition, powers and operation shall be as determined by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">The Board of Directors may delegate
its powers to one or more of its members or to an executive committee comprised of members of the Board of Directors and shall determine
the scope of their delegated authority and related restrictions, policies and procedures, in compliance with this corporate charter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">10.9 The Board of Directors may appoint one or more
deputy chairs and designate a Secretary, which need not be a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.10 If the Board of Directors
delegate some of its powers to one or more managing directors and/or an executive committee, they shall report to the full Board of Directors
at least every six months (or more frequently if resolved by the Board of Directors in delegating such powers) on their activities generally
and their expected activities as well as on the most important matters, in a quantitative or qualitative sense, carried out by the Company
or by any of its controlled subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.11 Shareholders acting at
a regular meeting may establish aggregate compensation for the entire Board of Directors, which the Board of Directors shall have authority
to allocate among individual directors on the basis of their respective duties and responsibilities, including service on specific committees
of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Members of the Board of Directors shall be entitled
to reimbursement of the expenses incurred in fulfilling to their responsibilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.12 The Board of Directors
may appoint such officers, agents and other representatives of the Company, which need not be employees of the Company, and delegate to
them such powers with respect to specific matters or categories of matters in the name and on behalf of the Company. The Board of Directors
may also appoint one or more General Managers, establishing their powers and duties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.13 The power to bind the Company
and to act as its legal representative with third parties and in front of courts shall belong to the Chairman of the Board of Directors,
the Deputy Chairman and such managing director(s), if any, in accordance with the powers delegated to them upon their appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.14 Notice of any meeting of
the Board of Directors shall be sent by the Chairman, the Deputy Chairman or any managing director by registered letter or e-mail to be
sent at least four calendar days prior to the meeting to each director and to the members of the Board of Auditors, or, in case of urgency,
by telegram or fax or by e-mail sent at least twenty-four hours before the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">The notice of a meeting must
indicate the place of the meeting, which may be the registered office or the Company or elsewhere, provided that it is in Italy, in another
country within the European Union or in the United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.15 Meetings of the Board of
Directors may also be held via teleconference or videoconference, provided that all directors in attendance can be identified, can participate
in the discussion and may hear and be heard live on the matters to be dealt with and acted upon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.16 Subject to satisfaction
of the above requirements, it is not necessary for the Chairman and the person acting as the secretary for the meeting to be present in
the same location. The meeting is deemed to be held in the location where the person acting as the secretary for the meeting is present.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Meetings of the Board of Directors
shall be chaired by the Chairman or, in the event of his or her absence, incapacity or refusal, by the Deputy Chairman or by a managing
director, if one has been appointed, or by a director designated by the directors present at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.17 Any director who has a
conflict of interest with respect to a matter to be acted upon must disclose it to the other directors according section 2391 of the Italian
Civil Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">10.18 Meetings of the Board of
Directors shall be deemed to have been validly held even in the absence of any formal call, provided that all directors and all members
of the Board of Auditors are in attendance, including via teleconference or videoconference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">10.19 Board of Directors&rsquo; resolutions shall
be set forth in minutes signed by the Chairman and the secretary of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TITLE VI</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 11 &ndash; Board of Auditors and Internal
Auditing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">11.1 The Board of Auditors shall consist of three
statutory and two alternate members and shall act in accordance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">The Board of Auditors shall be
elected on the basis of slates submitted by Shareholders, on which candidates must be listed in the order in which they will be elected
on the basis of the requisite vote. Slates shall be deposited at the Company&rsquo;s registered office no later than twenty-five calendar
days prior to the date set for the Shareholders&rsquo; Meeting for which the election of members of the Board of Auditors is on the agenda.
Any Shareholder, acting individually or through a nominee, may submit or join in the submission of a single slate and may cast its vote
for a single slate. Each candidate for election to the Board of Auditors may be listed on a single slate, and shall automatically be ineligible
for election if named on multiple slates. Only Shareholders who, alone or together with other Shareholders joining in the submission of
the slate, represent at least 6% of the voting rights at the Shareholders&rsquo; meeting at which members of the Board of Auditors are
to be elected, are eligible to submit the slates, such eligibility to be established by filing an appropriate certification to that effect.
Certification of the ownership of the number of shares necessary for submission of a slate must be produced at the time of deposit of
the slate or at a later date, provided that such certification is provided by the deadline for the deposit of a slate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Together with and at the same
time as the deposit of a slate, the following shall be filed, with failure to comply with such filing requirements leading to the candidates
named on the slate being automatically ineligible for election: (i) biographical information for each candidate; (ii) information on the
identity of the Shareholders who have submitted the slate, with an indication of the total percentage of the Company&rsquo;s share capital
held: (iii) consent by each candidate to be named in the slate and certification, under his/her own responsibility, that no grounds for
ineligibility or incompatibility to serve as a member of the Board of Auditors, as well as the satisfaction of the requirements prescribed
by applicable law to be an internal auditor, including those relating to independency, and (iv) such other statements or information as
required by law or applicable securities exchange rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Any slates submitted without compliance with the above
requirements shall be deemed not to have been submitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Members of the Board of Auditors
shall be elected as follows: a) candidates for election as auditors equal to two statutory members and one alternate for the Board of
Auditors shall be selected from the slate that receives the greatest number of votes cast (the &ldquo;Majority Slate&rdquo;) shall be
elected in the order in which they are listed on the slate; b) the remaining statutory member (who will act as President of the Board
of Auditors) and alternate for the Board of Auditors will be drawn from the slate that receives the second greatest number of votes cast
(the &ldquo;Minority Slate&rdquo;) so long as the Minority Slate is not connected in any way, directly or indirectly, with the Shareholders
who submitted or voted for the Majority Slate. In the event that the Majority Slate does not contain a sufficient number of candidates
to fill the number of vacancies on the Board of Auditors to be filled as provided in clause a) above, all candidates listed in the Majority
Slate shall be elected internal auditors and the remaining internal auditors shall be drawn from the Minority Slate according to the order
in which they are listed in such slate. The voting procedure according to slates provided above shall be applicable only in case of election
of the entire Board of Auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">In the event of a tie between
slates, a new vote shall be taken and the candidates obtaining the largest number of votes shall be elected without regard to the slate
on which they are listed or application of the slate voting mechanism.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Should a single slate be submitted,
the Shareholders eligible to vote at the meeting shall cast their vote on such slate and, so long as more votes are cast for such slate
than votes cast against such slate, all the members of the Board of Auditors shall be elected from that slate in accordance with applicable
law at the time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">If no slates are submitted, or
a single slate is submitted and such slate does not obtain the requisite number of votes, or the number of internal auditors to be elected
on the basis of the slates submitted is less than the full number of internal auditors to be elected, or the Board of Auditors is not
to be entirely elected, or it is otherwise not possible for any reason to elect the Board of Auditors in accordance with the provisions
of this title, the members of the Board of Auditors shall be elected at the Shareholders&rsquo; meeting in accordance with generally applicable
procedures and required majorities under applicable law, without application of the slate voting mechanism.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">In the event of the resignation
or removal termination of a member of the Board of Auditors who was drawn from the Majority Slate or from the Minority Slate, as the case
may be, alternate internal auditors drawn from the same slate shall fill the vacancy in declining order of age, subject to compliance
with the requirements of this corporate charter</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">regarding the composition of
the Board of Auditors. The election of internal auditors to fill other vacancies on the Board of Auditors pursuant to Article 2401 of
the Italian Civil Code shall be approved at a Shareholders&rsquo; Meeting with the affirmative vote of an absolute majority of those present
and voting and in compliance with the principle of the appropriate representation of minority shareholders. In the event of the removal
or resignation of an internal auditor chosen from the Minority Slate, the principle of appropriate representation of minority shareholders
shall be deemed to have been complied with is an alternate auditor drawn from the Minority Slate is appointed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">11.2 Should the Board of Auditors
also be engaged to audit the financial statements and accounts of the Company pursuant to section 2409-bis, par. 2, of the Italian Civil
Code, the Board of Auditors shall be comprised entirely of auditors listed in the applicable register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">11.3 Meetings of the Board of
Auditors may be held via teleconference or videoconference, provided that all internal auditors in attendance can be identified, can participate
in the discussion and may hear and be heard live on the matters to be dealt with and acted upon. The meeting shall be deemed to have been
held at the location where the President and the Secretary are present.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">11.4 For anything not provided
herein, the Italian Civil Code and applicable laws concerning internal audit committees and the auditing function shall apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="ex3-1_001.jpg" ALT="" style="width:200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TITLE VII</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 12 &ndash; Withdrawal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">12.1 Shareholders may exercise their right of withdrawal
in the cases and according to the procedures provided by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">12.2 However, withdrawal right shall be excluded for
those shareholders who have not taken part in or have voted against the resolutions concerning:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the introduction or removal of any restraint on circulation of the shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the extension of the Company&rsquo;s term.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TITLE VIII</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 13 &ndash; Financial statements and Profits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">13.1 The Company&rsquo;s fiscal
year shall end on 31 December of each year. At the end of each fiscal year, the Board of Directors shall have financial statements prepared
in accordance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">13.2 5% of the net profits resulting
from the year-end financial statements shall be set aside as legal reserves, until the aggregate amount allocated to such reserve equals
one fifth of the share capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">13.3 The remaining net profits
shall be available for the payment of dividends as approved at a meeting of Shareholders or for such other purposes as the Shareholders
will deem most appropriate or necessary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">13.4 Dividends not collected within five years following
the day on which they became payable shall be deemed forfeited back to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TITLE IX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 14 &ndash; Winding-up and Liquidation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Should the Company be wound up
at any time, the Shareholders acting at a duly called and convened meeting shall approve procedures to be followed for liquidation and
shall appoint one or more receivers or liquidators, as their powers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TITLE X</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Article 15 &ndash; Final provisions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Any matter not specifically provided
in this corporate charter shall be governed by the provisions of the Italian Civil Code and other applicable laws then in force with respect
to joint stock companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Without prejudice to the above,
disputes to which the Company, the directors and/or liquidators, shareholders or other persons who have acted in the interest and on behalf
of the Company are part of and which derive from, or are inherent to, the provisions of the United States Securities Act of 1933</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">and / or of the United States
Exchange Act of 1934, as subsequently amended and supplemented, and the related implementing provisions, are subject, as permitted by
applicable law, to the exclusive jurisdiction of the United States Federal Court of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The current bylaws are those currently in force, modified
at Article 6 following the partial subscription of the capital increase resolved on May 20, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex3-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #% M8# 2(  A$! Q$!_\0
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M>UA:SD!)BB@'(I#7HL!]!IN>*: QH0#QGUI:;@BDR:8#\TF12;2:3;@T .)
MHSWIK#-)U7;GF@!Y.!2!L]*C4'=@]*D.%H 7G% /%-#9.*4\4 *#S2TS:>N:
M V.M #N:6F[L]*3- #MPH# TPC S0#0!)13>:7- "T4F:-U !D4 @U&U(N1U
MH FS29IN:7!QQ0 ZD)Q30K \FG$@"@!:0L <4QG(/%.QD9[T +FEI@S3Q0 @
MS02!0>>E-*F@!=X)Q3LTSC&.] !]: '9I X)HVFFY#<#K0!)1484CG-.!S0
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MLHB0TBAA[U5_X2NQ5L&1?SKPPZIJ&HL2&?<>F*;_ &;K$IW;I* />D\3V#G
ME7\ZMVU_;W6?*8 _6OG=X=5M.6:2M/2_%-[ITR^8[8'J: /?UWD\]*<",\&N
M,\/^-X;]5BD8;C77H ZAXSD&@![\G%-EE2"(NQ&!3EZ\UA>*B\>F,R,1Q0!;
M.OV08*9%!/O5RWN%NUW1G*^M?.5WJ=W]LDQ.WRMZU[/X/O1%X2BN9I,GODT
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M=TC&_KG% 'D.M:NVI6L+9W,.M:GPZ)F\1A6X.VN7OX'L;YH", &NJ^'Y"^)
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MH77*@T +H_AJ[U:X\R568$UZ-I/P_M$C#RQC<*ZS2M(MM.@0*@#8K0;=G:O
MH Y2?P-92PD*H%>;>)_"QTUF>-#M!Y->Z-F., <FL#Q79Q2Z%,YCRV* / HI
M#;W"...:]U\#7_VK3 "V<"O"[^$I-@=FKTWX:7K;#"3UH ]/'!)'-5KNY2RM
MI)W;&!5M1M)%<#X]UDV]L\*'K0!Q/BSQ%+?73JCG:#QBL71=#N=9N@6#%<U0
M@\V[NPG4LU>W^"M%2QL5>1!N(]* *^A>"K6U5&D0$CMBNG&D6"#'DK^5: QG
M@8IK1@MG- &1=>&K"Y0_N5R?:O//$G@4P%Y(5R.O%>MD87K5:11<Q,LBY[4
M?.,,MQI.HX!8;3S7L'@_Q*+ZW2-GR1P:X_QYHAM)&GB0#/M6'X0U-[&]6-CC
M)H ^@VP0#ZUA>+2!HK'&>*T]/G%S:12>U9?B[G1' [T > 7@4W<C <9KH?\
MA)FMO#B643'/M7.S+_I<RY[UK>'-'.IWB(5RH- $NC>'+O6W$L@8J>YKT+1O
M $,*#SD'XUU6BZ5!IUHJB,# ]*U7^=0%.* .3N? MC(GRQBO/_%G@]=.4RI'
M\HKVW!6.L7Q-IZ7ND2$C) H ^>87>&0,F0P->W> M0%S8!2V7 Z5XOJ"_9[^
M2)1R#7H/PTEE\TC/% 'J[#S4=''!%83^%K*25I6C&<&M\L F>](#F)OH: /G
MOQ9!%:ZI+'&. 35SP/I\%[?A73)S47C6/&LS'_:-:'PX<?VN* /3H_"E@0"8
MA^56+?PY:VTNZ-0#6PA&P4X=: & !$"CM7/^+--?4;$JF>G:NC(S37"E=I&:
M /%-/\!2RW9\Q3@GO7>:7X(M+1%+(&]L5UL4,:#A!FG-OSTXH HQ:/90Q@"!
M?RIDVC6,RD>4.?:M+)Q@B@8':@#R[Q;X(MT1KF*/)'/%>9I(UK=L%!!0U])W
MT:7-K)&Z]J\#\5VJ6.NO$JX#4 >E?#O7!?6S1,^=O:N]'W37A'P]NGM-6,0;
M <U[JHS&G/:@!Z],44B]310 44E%0U<$A".IJO/")XV!%60,DTWN16D&T9U(
MW//-9M/(N"0.]4X_F6NOUZT$L1; R*Y($*"M>E"5XGG5(I,0#M3Q31P*<*EC
MIO47;NH8$X%+Y>>AJ:P02W !]:RE*QW1-K0K$'#,*WKZU2:U,8':GV5NL<*D
M "K# ,M<[G=ES=T>;ZC:F"8J!WJ.!..:ZG6M.$BENE8$,8#%/2B4[(X).S%S
MM&*9U-/E&#32>AKQ,5*['%B'@4(FXTJ\Y-6[.#S+I/3-<U*ES'5%&UHUF,!B
M*WUPIVU%;1+$@  '%3!1G->M2HJ)T"FFTN<TH%=25@$%!7YJ=0:!%+5+D6MG
M)*?X5S7SUXENA<ZI+<_WC7O'B>-I=)F1>I6OGW4 ?-D@;[RF@#LOAW8K->),
MPSS7M V@;0.E>2?#20>8L?<&O7< &@!%7'-'/)-!XYH)!% "9'4"HY?GAD##
MC;2A>>M*Y'E/]* /GKQ@J?VW,JC!!J]\.B5U\!NXQ5+QC&$\0RMGO5[P"?,\
M0#''% 'NT8"Q\>E>-_$FY9KHQ@\9KV1!B #OMKPOQVSQZW+NR0>F: .>T<I;
MW\3NW /->V:7XHL$TU4\Q00/6O XUDEF4+G-:YT;474-&T@'M0![='XOT[9@
M2*3]:!XNL<_?7\Z\332-353@O0-*U5N[T >W_P#"7Z?_ 'U_.FGQAIXY\Q?S
MKP]]*U;. TE.72=5QR7H ]0\5ZYI^HZ:^UU)"\<UX^LRRSAAQ\U79-'U0C&7
M(]*(]"O@ !"<Y]* /9_!%]]HTJ- ?NC%6?&1VZ62?0UF> K::SLPLR$9'>M3
MQDP_LAQC/!H ^?Y@'NWQ_?KUSP!8HL"N%&:\CF/^EOC^]7M'P\_Y!RT =NR_
M.*D[T?Q4=S0!'&, EO6J6LKYNE3J1D8K0[FJFH_\@V7Z4 ?.NMCRM5D3MFNT
M^'!/]H*!WKCO$7_(;F^M=C\./^/U: /7I7"(?7%>)?$"^/\ :!CSQFO;)P/L
M[>N*\"\=(W]L,3GK0!G:$T:ZFDDAPJG->SVWBG3UM8U$BC ]:\(B$SR!(^":
MT3H>IJ X=\&@#W$^+]."C$B_G2?\)CIW]]?SKP_^R-4X^9Z/['U3^\] 'N'_
M  F&G'^-?SI&\7Z:'"B1?SKQ#^R-4_O/2C1[\C.Z3- 'I7B_5+'4[%A&ZD@>
MM>46<@BOMP/1JL_V9JBY'[PCWI+?2+XW"[H6'/I0![IX6N/-TF(D_P -'BKG
M0W)J'PC:O#IJ!\@@5/XO&-"84 > 7)"WLA]6KU;X>:9'Y GP"37E=X!]I;CO
M7L7PZ_Y!"4 =TV H!%(PZ;:=UH'6@!">BFJ^H(/[/E!Z;:M#K5;4?^/"7Z4
M?._B%477)<>IKKOAS<8NBM<GXG _M>3CO74_#H#[6* /8P R4C_(A^AIPZCZ
M4-S&?H: /!O&G.J3'W-2_#DC^V15;QJ3_;,O^\:M?#S']MB@#W),>6*4FD3[
M@H9><T .!R*9QG)/2D+_ +W':N5\4^)ET@,JD4 ;E_K=I9 [I%R/>N7O?B+;
M6;$C#^U>6:KJMWK5^7BD?&>@-7M+\*7NHN#*K;3WH [D?%:VSS;T\_%6T&,V
M_P"M4K+X8PR1AI<@TZZ^&L2C$8)H VK;X@6%RN,CYJ\V\>3Q7NKK<0XZ=JT+
MSX?W]LLC0[N>F*Y"^@NK>[%I<9W#N: -KP8I;78>>AKZ C'[I">PKP'PA%LU
M^'![U[_'_JT'M0 X8(R**3&#10 E)12B@H3D9-,W8!)J1NE4+^Z6W@;GG%7%
M'/5G8Q=;U)=K1@URPY)8]ZFNIS<7+DGO477Y>U=U/1'G3E=BG[P]*<>O%(>,
M"G+C%*;L5 !(5I]K(8)=WO4?!-+(01Q7!4J'9%G<:5?B>$ FM(L *XS1[OR6
M )XKH;F_06NY&Y-81E=E.>AG:O??.4!K# *DOZU+<OYKER>:C#$IS14EH<<Q
MA!;FD'<4[<1P*:!SFO/G'F8X#2=L=/MKWR)T)/>HW(QCM5:5-Q!':NRA1.Z"
M/0]/N1<H"#5_@<5Q^@WYB(5CQ76*RR@.#S77RV+'A=M.I":*EL!>U'\-%'3B
MA#*6I1B2V8>U?/?B6V:UUR=L84FOHV1!(I!KQ_X@Z.8YWF5#@\YI@4OA[?);
M:@"YP":]N1EE4.IX(S7S+IEX]G,'4XP:]N\+>)([VUACD8!L8H Z_&!32N>:
M0DM@HP(IV<KZ&@! E13 )$Y8\8J3<-I/3%<MXI\20Z?I[J)%,OIF@#R3QB0^
MO2\]ZM_#_P"7Q&,>E<]>WIU+4)9GZYXKH_AX=WB#I0![NO$0/M7C_P 2;$K=
M>>!UKUX$^6 /2N1\;Z6M[IQ;;E@.* /&M'N574(U>$$9ZU[QH-K9W-@A-NF<
M>E> RQ/87NYP5P>*]2\%>)/,V0O(,=.M '?'2K'=_P >R_E0VDV('%LOY5:4
MEUW(P(-*K%>'ZT 5%TFP W&V7\J:VF6)/_'LOY5<<MMXJ.XG6WMR[<$"@" :
M5I^.;=/RI!I-DC9\I?RKC]1\>065SL?H#6OHWC"SUAQ'$.30!T<<4*C$:@?2
ML#QC@:2P]JWR4BQGO6!XQ4-I#,.XH \"GQ]K?_>KV;X=_P#(.6O&)R%O7'^U
M7M'P[_X\%],4 =W_ !4=S0?4=:09QS0 =S534?\ D&R_2K9XS534O^0;+]*
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MVEMIEDD;#D"KFK:-!JBG<H+8H \"TC5GT6??D@@UZKH'CB&ZA7SGQQ7&^(_
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M4 *K!ANIK(6.0:=\J<=J!R.#0 QMXP",CO4$VGVET?GB7/TJR,@\FE(!/'%
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M*R7,\JC'O64_C+18\XF&: .C.0.!2#<3R,"L6S\4V%\^V*4&MD-O3<&!'M0
MI4]C1D8^:F)N+=>*@O-0M[,9E8#'6@"4,J]<FGB93T!K$;Q?HL8YN5_*I+;Q
M+IMT^(9UH V0"3D=*=5>.?S,%""IZ$58% "T444 )@4;1Z4M% #<8-! /:E/
M6DH!ZB;%]!2\444"L@QBC HHH&%&!110*PFT'M1M7T%+11<.5"8'I2X'I110
M.P4444 %)M7TI:* # ]**** $QS3\4WO3J "BCO10 TBC%!ZT4 )@#M2T44
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MH 2BEQ1B@!**7%&* $HI<48H 2ES1BC% "T444 %%%% !1110 4444 %%%%
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M@!2H49J"21B,444 20\CGFG, &&!110 DO XIT9RO-%% "(@!)Q3B@/.***
M%%(R@T44 -8#:*=@444 (X&,TJ?=HHH 1@!SWH/W0>]%% "^E!4=:** (Q(2
H<5($&[=WHHH 4J#UJ-F\O %%% #P,BC8*** %QBBBB@ %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
